MAP kinase activation by mu opioid receptor in cord blood CD34+CD38− cells
- 31 May 2002
- journal article
- research article
- Published by Elsevier in Experimental Hematology
- Vol. 30 (5) , 473-480
- https://doi.org/10.1016/s0301-472x(02)00786-5
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Interest of cord blood stem cellsBiomedicine & Pharmacotherapy, 2001
- Mammalian MAP kinase signalling cascadesNature, 2001
- A functional role of mitogen-activated protein kinases, Erk1 and Erk2, in the differentiation of a human leukemia cell line, UT-7/GM: A possible key factor for cell fate determination toward erythroid and megakaryocytic lineagesInternational Journal of Hematology, 2001
- Survival function of ERK1/2 as IL-3-activated, staurosporine-resistant Bcl2 kinasesProceedings of the National Academy of Sciences, 2000
- Cell Survival Promoted by the Ras-MAPK Signaling Pathway by Transcription-Dependent and -Independent MechanismsScience, 1999
- MAP kinase activation by mu opioid receptor involves phosphatidylinositol 3‐kinase but not the cAMP/PKA pathwayFEBS Letters, 1999
- Biology of Human Umbilical Cord Blood‐Derived Hematopoietic Stem/Progenitor CellsThe International Journal of Cell Cloning, 1998
- Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age.Proceedings of the National Academy of Sciences, 1994
- Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults.Proceedings of the National Academy of Sciences, 1992
- Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells.Proceedings of the National Academy of Sciences, 1989